ResMed Inc. (RMD) to Issue Quarterly Dividend of $0.60 on June 18th

ResMed Inc. (NYSE:RMD) declared a quarterly dividend on Thursday, April 30th. Stockholders of record on Thursday, May 14th will be paid a dividend of 0.60 per share by the medical equipment provider on Thursday, June 18th. This represents a c) annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Thursday, May 14th.

ResMed has raised its dividend payment by an average of 0.1%per year over the last three years and has increased its dividend every year for the last 13 years. ResMed has a payout ratio of 22.7% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect ResMed to earn $12.11 per share next year, which means the company should continue to be able to cover its $2.40 annual dividend with an expected future payout ratio of 19.8%.

ResMed Trading Down 3.8%

RMD opened at $198.87 on Tuesday. The stock has a market capitalization of $28.97 billion, a P/E ratio of 19.18, a P/E/G ratio of 1.32 and a beta of 0.84. The company has a current ratio of 3.01, a quick ratio of 2.33 and a debt-to-equity ratio of 0.06. ResMed has a 12 month low of $198.61 and a 12 month high of $293.81. The firm’s fifty day simple moving average is $228.34 and its 200 day simple moving average is $244.10.

ResMed (NYSE:RMD) last announced its earnings results on Thursday, April 30th. The medical equipment provider reported $2.86 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.07. The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.42 billion. ResMed had a net margin of 27.44% and a return on equity of 25.35%. The company’s revenue for the quarter was up 10.8% compared to the same quarter last year. During the same period in the prior year, the business earned $2.37 EPS. As a group, research analysts anticipate that ResMed will post 11.13 EPS for the current fiscal year.

About ResMed

ResMed (NYSE: RMD) is a global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions. Founded in 1989, the company is headquartered in San Diego, California, and develops, manufactures and distributes a range of devices and software used by patients, clinicians and providers worldwide.

ResMed’s product portfolio centers on noninvasive ventilation and sleep therapy equipment, including continuous positive airway pressure (CPAP) and bilevel devices, masks and related accessories for the treatment of obstructive sleep apnea and other respiratory disorders.